Skip to main content
. 2019 Sep 17;10(53):5523–5533. doi: 10.18632/oncotarget.27148

Figure 2. Ramucirumab blocks both VEGF-A- and pediatric tumor cell-driven cord formation in vitro.

Figure 2

(Top) Representative images of cords from each condition are shown. (Bottom) Total tube area of VEGF-A- and tumor cell-driven cords is presented, with data for each cell line normalized to its respective untreated control. Black bars: untreated; gray bars: treated with 10 μg/mL ramucirumab. Error bars represent SEM.